NATURAL ALTERNATIVES INTERNATIONAL INC Repayments of Long-Term Debt
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) reported Repayments of Long-Term Debt of $228.00 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-05-19
- NATURAL ALTERNATIVES INTERNATIONAL INC repayments of long-term debt for the quarter ending 2026-03-31 was $76.00K, a 1.33% increase year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC repayments of long-term debt for the quarter ending 2025-12-31 was $78.00K, a 5.41% increase year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC repayments of long-term debt for the quarter ending 2025-09-30 was $74.00K, a 1.37% increase year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC repayments of long-term debt for the quarter ending 2025-06-30 was $74.00K, a 4.23% increase year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC repayments of long-term debt for fiscal 2025 was $296.00K, a 2.78% increase from fiscal 2024.
- NATURAL ALTERNATIVES INTERNATIONAL INC repayments of long-term debt for fiscal 2024 was $288.00K, a 3.60% increase from fiscal 2023.
- NATURAL ALTERNATIVES INTERNATIONAL INC repayments of long-term debt for fiscal 2023 was $278.00K, a 35.61% increase from fiscal 2022.
- NATURAL ALTERNATIVES INTERNATIONAL INC repayments of long-term debt for fiscal 2022 was $205.00K.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-03-31 | $76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-19 | $154.00K derived: sum of 2 quarters · filed 2026-05-19 | $228.00K 10-Q · filed 2026-05-19 | $302.00K derived: sum of 4 quarters · filed 2026-05-19 |
| 2025-12-31 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | $152.00K 10-Q · filed 2026-02-13 | $226.00K derived: sum of 3 quarters · filed 2026-02-13 | $301.00K derived: sum of 4 quarters · filed 2026-05-19 |
| 2025-09-30 | $74.00K 10-Q · filed 2025-11-12 | $148.00K derived: sum of 2 quarters · filed 2025-11-12 | $223.00K derived: sum of 3 quarters · filed 2026-05-19 | $297.00K derived: sum of 4 quarters · filed 2026-05-19 |
| 2025-06-30 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $149.00K derived: sum of 2 quarters · filed 2026-05-19 | $223.00K derived: sum of 3 quarters · filed 2026-05-19 | $296.00K 10-K · filed 2025-09-23 |
| 2025-03-31 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-19 | $149.00K derived: sum of 2 quarters · filed 2026-05-19 | $222.00K 10-Q · filed 2026-05-19 | $293.00K derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-31 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | $147.00K 10-Q · filed 2026-02-13 | $218.00K derived: sum of 3 quarters · filed 2026-02-13 | $289.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $73.00K 10-Q · filed 2025-11-12 | $144.00K derived: sum of 2 quarters · filed 2025-11-12 | $215.00K derived: sum of 3 quarters · filed 2025-11-12 | $288.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $142.00K derived: sum of 2 quarters · filed 2025-09-23 | $215.00K derived: sum of 3 quarters · filed 2025-09-23 | $288.00K 10-K · filed 2025-09-23 |
| 2024-03-31 | $71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $144.00K derived: sum of 2 quarters · filed 2025-05-14 | $217.00K 10-Q · filed 2025-05-14 | $286.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | $146.00K 10-Q · filed 2025-02-14 | $215.00K derived: sum of 3 quarters · filed 2025-02-14 | $286.00K derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | $73.00K 10-Q · filed 2024-11-13 | $142.00K derived: sum of 2 quarters · filed 2024-11-13 | $213.00K derived: sum of 3 quarters · filed 2024-11-13 | $283.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27 | $140.00K derived: sum of 2 quarters · filed 2024-09-27 | $210.00K derived: sum of 3 quarters · filed 2024-09-27 | $278.00K 10-K · filed 2024-09-27 |
| 2023-03-31 | $71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | $141.00K derived: sum of 2 quarters · filed 2024-05-14 | $209.00K 10-Q · filed 2024-05-14 | $277.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | $138.00K 10-Q · filed 2024-02-13 | $206.00K derived: sum of 3 quarters · filed 2024-02-13 | $275.00K derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-09-30 | $68.00K 10-Q · filed 2023-11-09 | $136.00K derived: sum of 2 quarters · filed 2023-11-09 | $205.00K derived: sum of 3 quarters · filed 2023-11-09 | |
| 2022-06-30 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-21 | $137.00K derived: sum of 2 quarters · filed 2023-09-21 | $205.00K 10-K · filed 2023-09-21 | |
| 2022-03-31 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $137.00K 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | $68.00K 10-Q · filed 2023-02-08 | |||
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-21 | $0.00 derived: sum of 2 quarters · filed 2022-09-21 | $0.00 10-K · filed 2022-09-21 | |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $0.00 10-Q · filed 2022-05-13 | ||
| 2020-12-31 | $0.00 10-Q · filed 2022-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |